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or treating children’s fractures, with minimal long-term compli-
ations.
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biodegradable scaffold for the treatment of a diaphyseal bone
efect of the tibia
.R.T. Kuzyka,b,∗, E.H. Schemitscha,b, J.E.D. Daviesa
University of Toronto, Canada
St. Michael’s Hospital, Canada
urpose: The aim of our study was to evaluate bone formation and
ngiogenesis producedwithin a biodegradable poly-d,l-lactide-co-
lycolide acid / calcium phosphate (PLGA/CaP) scaffold when used
o treat a diaphyseal tibia defect.
ethods: Canine tibiae were reamed to 7.0mm and ﬁxed with a
.5mm statically locked intramedullary nail after creation of an
.0mm diaphyseal defect. Eighteen canines were allotted into 3
reatment groups: (1) empty (N=5), (2) iliac crest autograft (N=6),
r (3) PLGA/CaP biodegradable scaffold (Tissue Regeneration Ther-
peutics Inc., ON, Canada) (N=7).
Fluorescent labels were given at 6, 9, 11 and 14 weeks. Animals
ere sacriﬁced at 15weeks and perfusedwith a barium compound.
amples were analyzed with radiography, Micro CT, and brightﬁeld
nd ﬂuorescent microscopy.
esults: Bone and vasculature volume within the tibial defect site
ere reported as a percentage of the total volume of the defect site.
he percent bone volume within the defect site was not different
etween treatment groups (p=0.112). There was greater percent
asculature volume in the scaffold group than the autograft group
p<0.001).
Bone formation at the osteotomy sites was deﬁned as the dis-
ance from the original osteotomy site to the tip of newly formed
one. Osteotomy bone formation was signiﬁcantly greater in the
caffold group than the autograft group (p=0.015). Osteotomy sites
ssociated with greater angiogenesis displayed greater bone for-
ation.
Bone formation rates were reported as the distance between
he ﬂuorescent bone labels. Autograft samples had the greatest
one formation rates within the periosteum. Autograft and scaf-
old samples had the greatest rate of bone formation within the
ortex.
onclusions: Our canine tibial defect model provides a satisfactory
acsimile of the traumatic tibia fracture with associated bone loss.
he PLGA/CaP biodegradable scaffold we have employed promotes
ngiogenesis within a defect and could be used with autografting.
eywords: Bone defect; Scaffold for bone; Tibia fracture; Bone sub-
titute
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esults of use of bone morphogenic protein-2 (BMP-2) in the
reatment of long bone fracture non-union—A series of 25 cases
. Ramisetty ∗, A. Nargol
Northtees General Hospital, UKntroduction: BoneMorphogenic Protein2 (BMP-2)has beenusedas
bonesubstitute invariousorthopaedicprocedures including spine
urgery and acute high energy open tibial fractures with bone loss.
here were no reported series in the literature in the use of BMP-20 (2009) 183–235 229
as the bone graft in the fracture non-union treatment. Our aim was
to use BMP-2 in non-unions and to review the results.
Methods: We have treated 25 long bone fracture non-unions over a
period of 2 years with BMP-2 during surgical ﬁxation. We followed
all the patients until union or failure requiring further surgery.
Functional assessment was performed by short musculoskeletal
functional assessment score (SMFA). 20 patients had BMP-2 only as
the bone graft (group-1). 5 patients had iliac crest graft in addition
to BMP-2 (group-2).
Results: There were 15 males and 10 females. Non-unions were
spread across clavicle (4), humerus (3), ulna (2), femur (8), tibia
(6) and lateral malleolus (2). 18 cases (90%) in group-1 and 5 cases
(100%) in group-2 had clinical and radiological union. The mean
time fromoriginal fracture to surgical interventionwith BMP-2was
15.21 months. Mean time from intervention with BMP-2 to further
union was 7.43 months. There were no complications with use of
BMP-2 either intra or postoperatively. The mean SMFA score has
improved from 66.6 to 34.9.
Conclusion: BMP-2 may be an alternative to autologous bone graft-
ing to avoid donor site morbidity in management of fracture
non-union and can produce good results. Further studies with
randomisation between autologous bone graft and BMP-2 will be
required.
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BMPs and non-unions: A prospective randomised clinical study
on 120 patients
G.M. Calori ∗, W. Albisetti, T. Tagliabue
University of Milan, Italy
The purpose of this prospective randomised study, conducted
between April 2005 and August 2007 at the Orthopaedic Institute
G. Pini (University of Milan), was to compare the efﬁcacy of recom-
binant bone morphogenetic protein 7 (rhBMP-7) and Platelet Rich
Plasma (PRP) as bone-stimulating agents in the treatment of per-
sistent fracture non-unions.
Long Bone NU is a very challenging condition that require ade-
quate mechanical stabilization and often a concomitant biologic
stimulation; to date, apart the use of Autologous Bone Graft (ABG)
still considered the golden standard, BoneGrowth Factors are avail-
able in clinical practice: recombinant human BMPs (rhBMP-7) or
AutologousGrowthFactors (AGFs) contained inPlateletRichPlasma
(PRP).
One hundred and twenty patients were randomised into two
treatment groups (group rhBMP-7 vs group PRP). The number of
males and females was 32 M–28 F for the rhBMP-7 group and 35
M–25 F for the PRP group. Sixty patients with sixty fracture non-
unions were assigned to each group (median age: 46.4±1.98 years
for the rhBMP-7 group and 42.5±1.76 years for the PRP group).
Each patient underwent non-emergent operation for the treatment
of their atrophic non-union, where adjuvant bone grafts were used
according to the surgeon’s preference. Revision of ﬁxation method
was implemented when deemed necessary.
In the rhBMP-7 group there were ﬁfteen tibial non-unions, ten
femoral, ﬁfteen humeral, twelve ulnar, and eight radial non-unions.
In the PRP group there were nineteen tibial non-unions, eight
femoral, sixteen humeral, eight ulnar, and nine radial non-unions.
The median number of operations performed prior to our interven-
tion was 2.6±0.62 and 2.7±0.74 with autologous bone graft being
used in twenty-three and twenty-one cases for the rhBMP-7 and
PRP groups, respectively.
